Biostage, Inc.·4

Jan 27, 10:52 AM ET

GREEN DAVID 4

4 · Biostage, Inc. · Filed Jan 27, 2023

Insider Transaction Report

Form 4
Period: 2023-01-25
GREEN DAVID
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-25+47,65147,651 total
    Exercise: $6.46Exp: 2033-01-25Common Stock, par value $0.01 per share (47,651 underlying)
Footnotes (1)
  • [F1]Subject to continued employment through the applicable vesting dates, the non-qualified stock option will vest monthly in twelve equal monthly installments on each monthly anniversary of January 25, 2023.

Documents

1 file
  • 4
    form4-01272023_030146.xmlPrimary